Yes, I think this is actually positive for Neuren. It seems to me Acadia has been trying to downplay the importance of Trofinitide & NNZ-2591 to their future plans, possibly because they want to maintain a strong negotiating position with Neuren regarding any future deals. Hence their investment in the prader willi trial and continuing to try extending their existing drug (despite multiple failures). I don't think Acadia wants to look like a one trick pony entirely dependent upon Neuren's licensed drugs. However, with this failure, this is increasingly what they are.
Their bluffs are being called.
I suspect they may soon have to suck it up and announce they're putting significant efforts into developing NNZ-2591 for Fragile-X and Retts - as their best remaining options for the future of their business.
I wouldn't be surprised if we hear about another failure soon on their current Ph 3 trial for prader-willi hyperphagia. and I wonder how the Alzheimers Disease Psychosis trial is going too?
- Forums
- ASX - By Stock
- Acadia
Yes, I think this is actually positive for Neuren. It seems to...
- There are more pages in this discussion • 238 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.80 |
Change
-0.160(0.76%) |
Mkt cap ! $2.619B |
Open | High | Low | Value | Volume |
$21.00 | $21.21 | $20.31 | $11.90M | 578.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 451 | $20.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.81 | 531 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 192 | 20.610 |
6 | 276 | 20.600 |
8 | 491 | 20.590 |
5 | 333 | 20.580 |
6 | 246 | 20.570 |
Price($) | Vol. | No. |
---|---|---|
20.620 | 539 | 13 |
20.630 | 501 | 8 |
20.640 | 247 | 4 |
20.650 | 335 | 4 |
20.660 | 348 | 4 |
Last trade - 15.19pm 30/05/2024 (20 minute delay) ? |
|
|||||
Last
$20.82 |
  |
Change
-0.160 ( 1.17 %) |
|||
Open | High | Low | Volume | ||
$20.97 | $21.15 | $20.32 | 184151 | ||
Last updated 15.40pm 30/05/2024 ? |
Featured News
NEU (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online